Vaccine News and Research

Latest Vaccine News and Research

Routine immunization virtually eliminates major killer of young children in the Gambia

The Lancet has today published online new research from a team led by the UK Medical Research Council's Richard Adegbola showing that routinely vaccinating infants against H. influenzae type b (Hib) - a bacterium that causes deadly diseases including pneumonia and meningitis - has virtually eliminated Hib meningitis in The Gambia.

29 Jun 2005

MRC study finds vaccine eliminates HIB disease in the Gambia

A Medical Research Council (MRC) study results, announced online today in The Lancet, illustrate that a routine immunisation programme in The Gambia has been successful at eliminating the incidence of Haemophilus influenzae type b (Hib) disease.

28 Jun 2005

Routine immunisation against meningitis and pneumonia should be introduced for children in developing countries

Routine immunisation against a bacterial microorganism that can cause meningitis and pneumonia should be introduced for children in developing countries, suggests a report published in this week’s issue of The Lancet.

28 Jun 2005

Grand Challenges in Global Health awards $450m to top scientists

Grants totalling U.S $450m were awarded yesterday to some of the world's most inventive scientists to enable them to turn their novel ideas into practical solutions to the 14 greatest problems plaguing human health today.

28 Jun 2005

Vaccine against Lassa fever works in monkeys

Scientists say that a genetically engineered virus may possibly offer the first effective vaccine against Lassa fever.

28 Jun 2005

New candidate for a vaccine against Lassa fever

Among the family of viral hemorrhagic fevers (which includes those caused by the Ebola, Marburg, and Hanta viruses), Lassa fever is the biggest public health problem.

28 Jun 2005

Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine

Mice given a relatively new cancer drug can survive an otherwise lethal dose of vaccinia virus, a relative of smallpox virus, report scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID).

27 Jun 2005

$5.1 billion could save 6 million children

Six million children could be saved if $5.1 billion in new resources for preventive and therapeutic interventions were provided each year, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions.

27 Jun 2005

OHSU scientists say low FOXP3 means fewer disease-fighting cells, but new drug may help multiple sclerosis

Oregon Health & Science University researchers have measured genetic changes reflecting a drop in the body's ability to suppress inflammatory cells that attack nerve fibers and promote progression of multiple sclerosis.

27 Jun 2005

Half a million in U.S. could die in flu pandemic

A report from the Trust for America's Health, says the United States only has 965,256 staffed hospital beds, and in the event of a pandemic, half a million Americans could die and more than 2 million could end up in the hospital with serious complications.

27 Jun 2005

3 health workers arrested after hepatitis vaccine kills a schoolchild and makes 120 others ill

After a hepatitis vaccine was administered in their schools in central China, one child died and another 120 have become ill.

27 Jun 2005

Expert says the world is not ready for the next pandemic

Michael T. Osterholm is Director of the Center for Infectious Disease Research and Policy, Associate Director of the Department of Homeland Security's National Center for Food Protection and Defense, and Professor at the University of Minnesota's School of Public Health.

21 Jun 2005

New Zealand Ministry of Health warns Influenza B can be serious health risk to children and young people

A currently-circulating strain of influenza has not been common in New Zealand since 1987 and means children and young people can be at particular risk of serious illness, the Ministry of Health says.

21 Jun 2005

Partnership to develop an AIDS vaccine using a promising new technology

GlaxoSmithKline Biologicals (GSK Biologicals) and the International AIDS Vaccine Initiative (IAVI) today announced a public-private partnership to develop an AIDS vaccine using a promising new technology.

21 Jun 2005

Drug for schizophrenia can prevent and treat SARS

Chinese and European experts at a conference of the Sino-European Project on SARS Diagnostics and Antivirals in China say that a drug normally used to treat schizophrenia has been shown to prevent and treat Severe Acute Respiratory Syndrome (SARS).

20 Jun 2005

Studies show Alzheimer's prevented by drinking juice daily and having the occasional alcoholic drink

At a conference in the U.S. on Alzheimer's disease on June 19, researchers said that they think brain scans and simple blood tests may offer the best ways to predict who has the highest risk of Alzheimer's disease.

20 Jun 2005

Female bed-rest study will understand changes to the immune response and decreased resistance to infection in space

A bed-rest study with female participants will help scientists understand changes to the immune response and decreased resistance to infection in space.

16 Jun 2005

Findings may help scientists improve the existing vaccine for yellow fever

In one of the first molecular studies of the human antibody response to yellow fever, Howard Hughes Medical Institute (HHMI) researchers and their colleagues have found the crucial bit of virus that people's immune systems need to spot and quash this often-fatal re-emerging disease.

16 Jun 2005

Immune system discovery could help in the treatment of bowel cancer

Scientists investigating whipworms, parasites that infect one-fifth of the world's population as well as livestock and domestic animals, have discovered a new way that the body effectively eliminates the parasites.

From The University of Manchester 16 Jun 2005

Vical receives $12 Million HIV vaccine order

Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.

16 Jun 2005

Vaccine News and Research

Latest Vaccine News and Research

Routine immunization virtually eliminates major killer of young children in the Gambia

MRC study finds vaccine eliminates HIB disease in the Gambia

Routine immunisation against meningitis and pneumonia should be introduced for children in developing countries

Grand Challenges in Global Health awards $450m to top scientists

Vaccine against Lassa fever works in monkeys

New candidate for a vaccine against Lassa fever

Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine

$5.1 billion could save 6 million children

OHSU scientists say low FOXP3 means fewer disease-fighting cells, but new drug may help multiple sclerosis

Half a million in U.S. could die in flu pandemic

3 health workers arrested after hepatitis vaccine kills a schoolchild and makes 120 others ill

Expert says the world is not ready for the next pandemic

New Zealand Ministry of Health warns Influenza B can be serious health risk to children and young people

Partnership to develop an AIDS vaccine using a promising new technology

Drug for schizophrenia can prevent and treat SARS

Studies show Alzheimer's prevented by drinking juice daily and having the occasional alcoholic drink

Female bed-rest study will understand changes to the immune response and decreased resistance to infection in space

Findings may help scientists improve the existing vaccine for yellow fever

Immune system discovery could help in the treatment of bowel cancer

Vical receives $12 Million HIV vaccine order

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in